Actively Recruiting
Study to Estimate the Prevalence and Care of Advanced Stage 4 Chronic Kidney Disease in Adults in Gard, France Using Lab and Nephrology Data
Led by Centre Hospitalier Universitaire de Nīmes · Updated on 2026-10-20
3375
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This observational study aims to assess the feasibility of estimating how common stage 4 and 5 chronic kidney disease CKD is in the Gard department of France. Researchers will compare data from laboratory databases with records of patients seen by nephrologists to understand if laboratory-verified care needs match actual nephrology care delivery as recommended by the French High Authority of Health HAS. The study does not involve any treatments or interventions but focuses on analyzing existing laboratory data and nephrology patient records over a 12-month period. The primary goal is to measure the prevalence of advanced CKD in the region and evaluate how well patients with CKD are identified and managed by nephrologists. Participants with stage 4 or higher CKD will be observed through data collected from laboratories and nephrologists. Researchers will measure the number and proportion of patients with advanced CKD, assess reporting accuracy by nephrologists, and identify patients not seen by nephrologists. The study will last until December 2027, with ongoing data collection and analysis for up to 12 months.
CONDITIONS
Brief Title
Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France
Research Team
O
Olivier Moranne, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here